Thus, one can speculate that the absence of this tolerogenic signal upon reduced fucosylation due to the potentially intestinal microbiome-mediated occurrence of GDP-L-fucose synthase-reactive CD4+ T cells contributes to the neuroinflammatory state of the CNS of MS patients. This evidence concerns the gene CD4 and myeloid sarcoma.